Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma

Affiliations

Editorial

Jung-Jyh Hung. J Thorac Dis. 2017 Oct.

. 2017 Oct;9(10):3623-3625.

doi: 10.21037/jtd.2017.09.129.

¹ Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General Hospital and School of Medicine, National Yang-Ming University, Taipei, Taiwan.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Relationship of Lymph Node Micrometastasis and Micropapillary Component and Their Joint Influence on Prognosis of Patients With Stage I Lung Adenocarcinoma.
Dai C, Xie H, Kadeer X, Su H, Xie D, Ren Y, She Y, Zhu E, Fan Z, Chen T, Qin L, Zheng H, Zhang L, Jiang G, Wu C, Chen C. Dai C, et al. Am J Surg Pathol. 2017 Sep;41(9):1212-1220. doi: 10.1097/PAS.0000000000000901. Am J Surg Pathol. 2017. PMID: 28692600

1. Scott WJ, Howington J, Feigenberg S, et al. Treatment of Non-small Cell Lung Cancer Stage I and Stage II: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest 2007;132:234S-242S. - PubMed
1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22. 10.1016/0003-4975(95)00537-U - DOI - PubMed
1. Darling GE, Allen MS, Decker PA, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011;141:662-70. 10.1016/j.jtcvs.2010.11.008 - DOI - PMC - PubMed
1. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6:244-85. 10.1097/JTO.0b013e318206a221 - DOI - PMC - PubMed
1. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-64. 10.1038/modpathol.2010.232 - DOI - PubMed